NMS Capital announced that it has formed Flourish Research, which aims to become a leading, nationwide network of clinical research sites with therapeutic area and clinical trial phase diversity. For its initial investment in Flourish Research, NMS has completed the recapitalization of Clinical Trials of Texas in partnership with Founder Kay Scroggins and company management. Terms of the transaction were not disclosed. Read more.
NMS Capital Forms Flourish Research and Investment in Clinical Trials of Texas
